Literature DB >> 17015271

Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats.

Ram K Sindhu1, Ja-Ryung Koo, Kunal K Sindhu, Ashkan Ehdaie, Farbod Farmand, Christian K Roberts.   

Abstract

The present investigation was carried out to study the expression of major cytochrome P450 (CYP) isozymes in streptozotocin-induced diabetes with concomitant insulin therapy. Male Sprague-Dawley rats were randomly assigned to untreated control, streptozotocin-induced diabetic, insulin-treated groups and monitored for 4 weeks. Uncontrolled hyperglycemia in the early phase of diabetes resulted in differential regulation of cytochrome P450 isozymes. CYP1B1, CYP1A2, heme oxygenase (HO)-2 proteins and CYP1A2-dependent 7-ethoxyresorufin O-deethylase (EROD) activity were upregulated in the hepatic microsomes of diabetic rats. Insulin therapy ameliorated EROD activity and the expression of CYP1A2, CYP1B1 and HO-2 proteins. In addition, CYP2B1 and 2E1 proteins were markedly induced in the diabetic group. Insulin therapy resulted in complete amelioration of CYP2E1 whereas CYP2B1 protein was partially ameliorated. By contrast, CYP2C11 protein was decreased over 99% in the diabetic group and was partially ameliorated by insulin therapy. These results demonstrate widespread alterations in the expression of CYP isozymes in diabetic rats that are ameliorated by insulin therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015271     DOI: 10.1080/10715760600801272

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  10 in total

1.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

2.  Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients.

Authors:  Teresa Maria J P Carvalho; Ricardo de Carvalho Cavalli; Sérgio P Cunha; Cláudia O de Baraldi; Maria P Marques; Natalícia J Antunes; Ana Leonor P C Godoy; Vera Lucia Lanchote
Journal:  Eur J Clin Pharmacol       Date:  2010-09-17       Impact factor: 2.953

3.  Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.

Authors:  C Y Ahn; S K Bae; S H Bae; T Kim; Y S Jung; Y C Kim; M G Lee; W G Shin
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

4.  Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes.

Authors:  Bingning Dong; Mohammed Qatanani; David D Moore
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

5.  Mechanism of Hepatoprotective Effect of Boesenbergia rotunda in Thioacetamide-Induced Liver Damage in Rats.

Authors:  Suzy M Salama; Mahmood A Abdulla; Ahmed S Alrashdi; A Hamid A Hadi
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-07       Impact factor: 2.629

6.  Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats.

Authors:  Junjun Wang; Ting Zhai; Yong Chen
Journal:  Int J Mol Sci       Date:  2018-03-12       Impact factor: 5.923

Review 7.  Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

Authors:  Imadeldin Elfaki; Rashid Mir; Fahad M Almutairi; Faisel M Abu Duhier
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

8.  Protective effect of Ruellia tuberosa L. extracts against abnormal expression of hepatic detoxification enzymes in diabetic rats.

Authors:  Wen-Chang Chang; Da-Wei Huang; Jou-An Chen; Yu-Fang Chang; James Swi-Bea Wu; Szu-Chuan Shen
Journal:  RSC Adv       Date:  2018-06-13       Impact factor: 4.036

Review 9.  The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.

Authors:  Kuo-Chen Wu; Chun-Jung Lin
Journal:  J Food Drug Anal       Date:  2018-12-04       Impact factor: 6.157

10.  DT-678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y12 antagonists.

Authors:  Dale A Lauver; Dawn S Kuszynski; Barbara D Christian; Matthew P Bernard; James P Teuber; Bruce E Markham; Yuqing E Chen; Haoming Zhang
Journal:  Pharmacol Res Perspect       Date:  2019-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.